2-(2-甲氧基乙氧基)苯硼酸 | 1122568-09-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 中文名称: 2-(2-甲氧基乙氧基)苯硼酸
• 中文别名: 2-(2-甲氧基乙氧基)苯基硼酸
• 英文名称: [2-(2 -methoxyethoxy)phenyl]boronic acid
• 英文别名: (2-(2-Methoxyethoxy)phenyl)boronic acid；[2-(2-methoxyethoxy)phenyl]boronic acid
• CAS: 1122568-09-5
• 化学式: C₉H₁₃BO₄
• 分子量: 196.011
• InChiKey: FVUUWXVSSBFFPS-UHFFFAOYSA-N

物化性质

• 熔点：
  48-55°C
• 溶解度：
  可溶于DMSO（少许）、甲醇（少许）

计算性质

• 辛醇/水分配系数(LogP)：
  -0.61
• 重原子数：
  14
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  58.9
• 氢给体数：
  2
• 氢受体数：
  4

安全信息

• 包装等级：
  III
• 危险类别：
  6.1
• 危险性防范说明：
  P261,P280,P301+P312,P302+P352,P305+P351+P338
• 危险品运输编号：
  2811
• 危险性描述：
  H301
• 储存条件：
  2-8°C

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 2-(2-Methoxyethoxy)phenylboronic acid
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 2-(2-Methoxyethoxy)phenylboronic acid
CAS number: 1122568-09-5

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C9H13BO4
Molecular weight: 196.0

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-(2-甲氧基乙氧基)苯硼酸 在 bis-triphenylphosphine-palladium(II) chloride 、 二氯双[二叔丁基-(4-二甲基氨基苯基)膦]钯(II) 、 lithium hydroxide monohydrate 、 palladium diacetate 、 三溴化硼 、 caesium carbonate 作用下， 以 四氢呋喃 、 1,4-二氧六环 、 二氯甲烷 、 水 为溶剂， 生成 (2R)-2-{[(5Sa)-5-{3-chloro-2-methyl-4-[3-(4-methylpiperazin-1-yl)propoxy]phenyl}-6-(4-fluorophenyl)thieno[2,3-d]pyrimidin-4-yl]oxy}-3-[2-({2-[2-(2-hydroxyethoxy)phenyl]pyrimidin-4-yl}methoxy)phenyl]propanoic acid
  参考文献：
  名称：

  [EN] NEW HYDROXYACID DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
  [FR] NOUVEAUX DÉRIVÉS D'HYDROXYACIDE, LEUR PROCÉDÉ DE PRÉPARATION, ET COMPOSITIONS PHARMACEUTIQUES LES CONTENANT

  摘要：

  式(I)的化合物：其中R1、R2、R3、R4、R5、R6、R7、R8、R14、A和n的定义如描述所示。药物。

  公开号：

  WO2016207216A1
• 作为产物：
  描述：

  1-iodo-2-(2-methoxyethoxy)benzene 在 正丁基锂 、 硼酸三异丙酯 、 盐酸 、 水 作用下， 以 四氢呋喃 、 正己烷 、 甲苯 为溶剂， 生成 2-(2-甲氧基乙氧基)苯硼酸
  参考文献：
  名称：

  [EN] CYCLIC INDOLE-3-CARBOXAMIDES, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS
  [FR] INDOLE-3-CARBOXAMIDES CYCLIQUES, LEUR PRÉPARATION ET LEUR UTILISATION COMME PRODUITS PHARMACEUTIQUES

  摘要：

  公开号：

  WO2009095163A3

文献信息

• [EN] COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF<br/>[FR] INHIBITEURS DE TRADUCTION DU COLLAGÈNE 1 ET LEURS PROCÉDÉS D'UTILISATION
  申请人：ANIMA BIOTECH INC

  公开号：WO2021252555A1

  公开（公告）日：2021-12-16

  The present invention relates to novel Collagen 1 translation inhibitors, composition and methods of preparation thereof, and uses thereof for treating Fibrosis including lung, liver, kidney, cardiac and dermal fibrosis, IPF, wound healing, scarring and Gingival fibromatosis, Systemic Sclerosis, and alcoholic and non-alcoholic steatohepatitis (NASH).

  本发明涉及新型胶原蛋白1翻译抑制剂，其组成物及其制备方法，以及用于治疗包括肺部、肝脏、肾脏、心脏和皮肤纤维化、IPF、伤口愈合、瘢痕和牙龈纤维瘤病、全身性硬皮病，以及酒精性和非酒精性脂肪肝（NASH）的用途。
• Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals
  申请人：Sanofi-Aventis

  公开号：US08211885B2

  公开（公告）日：2012-07-03

  The present invention relates to cyclic indole-3-carboxamides of the formula I, wherein A, R, R10, R20, R30, R40, n, p and q have the meanings indicated in the claims, which are valuable pharmaceutical active compounds. Specifically, they inhibit the enzyme renin and modulate the activity of the renin-angiotensin system, and are useful for the treatment of diseases such as hypertension, for example. The invention furthermore relates to processes for the preparation of the compounds of the formula I, their use and pharmaceutical compositions comprising them.

  本发明涉及公式I的环状吲哚-3-羧酰胺，其中A、R、R10、R20、R30、R40、n、p和q具有所述权利要求中指示的含义，这些化合物是有价值的药物活性化合物。具体来说，它们抑制酶肾素并调节肾素-血管紧张素系统的活性，可用于治疗高血压等疾病。此外，本发明还涉及制备公式I化合物的方法、它们的用途以及包括它们的药物组合物。
• CYCLIC INDOLE-3-CARBOXAMIDES, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS
  申请人：STEINHAGEN Henning

  公开号：US20110039830A1

  公开（公告）日：2011-02-17

  The present invention relates to cyclic indole-3-carboxamides of the formula I, wherein A, R, R 10 , R 20 , R 30 , R 40 , n, p and q have the meanings indicated in the claims, which are valuable pharmaceutical active compounds. Specifically, they inhibit the enzyme renin and modulate the activity of the renin-angiotensin system, and are useful for the treatment of diseases such as hypertension, for example. The invention furthermore relates to processes for the preparation of the compounds of the formula I, their use and pharmaceutical compositions comprising them.

  本发明涉及公式I的环状吲哚-3-羧酰胺，其中A、R、R10、R20、R30、R40、n、p和q在权利要求书中所示，它们是有价值的药物活性化合物。具体而言，它们抑制酶肾素并调节肾素-血管紧张素系统的活性，可用于治疗高血压等疾病。本发明还涉及公式I化合物的制备方法、它们的使用以及包含它们的药物组合物。
• Hydrogen bonds in phenylboronic acids with polyoxaalkyl substituents at ortho-position
  作者：Agnieszka Adamczyk-Woźniak、Michał K. Cyrański、Aldona Dąbrowska、Błażej Gierczyk、Paulina Klimentowska、Grzegorz Schroeder、Anna Żubrowska、Andrzej Sporzyński

  DOI：10.1016/j.molstruc.2008.12.006

  日期：2009.2

  Phenylboronic acids with polyoxaalkyl substituents at ortho position were synthesized from the corresponding bromides. Structures in solid state, determined by single crystal X-ray diffraction, reveal the presence of inter- and intramolecular hydrogen bonds. Presence of several oxygen atoms in oxaalkyl chains enables the formation of intramolecular hydrogen bonds by B(OH)(2) group with different oxygen centers which lead to the formation of bifurcated hydrogen bonds. Investigated compounds were characterized by H-1, C-13, B-11 and O-17 NMR spectroscopy in solution. Assignment of H-1 and C-13 signals was made on the basis of HSQC and HMBC spectra. O-17 NMR spectra show that in acetonitrile solution hydrogen bonds with solvent molecules are predominant. (C) 2008 Elsevier B.V. All rights reserved.
• WO2023/154282
  申请人：——

  公开号：——

  公开（公告）日：——